Company attributes
Venture Capital Firm attributes
Other attributes
Grand Angels is an angel group in Michigan that focuses on B2B technology, advanced manufacturing, agriculture technology, and life sciences companies that are currently generating revenues, or are pre-revenue with a clear path to exit. Founded 2004 in Holland, Michigan, United States by Charles C. Stoddard and Craig T. Hall, this angel group invests in early stage ventures and seed. Its portfolio companies include Ocuphire Pharma, Ambiq Micro, HistoSonics, Micro-LAM Technologies, Tetra Discovery, Reconstruct, Blue Medora, Gemphire Therapeutics, and HistoSonics. As of February 2020, Grand Angels has made 18 investments. Their most recent investment was on July 22, 2019, when Ocuphire Pharma raised $5M. Grand Angels has raised two funds, their latest being Grand Angels fund III. This fund was announced on Feb 9, 2020 and raised a total of $11.8M.
